Kawachinagano, Japan

Nobuharu Andoh



Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Osaka, JP (1994 - 1998)
  • Sakai, JP (2001)
  • Kawachinagano, JP (2018 - 2019)

Company Filing History:


Years Active: 1994-2019

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Nobuharu Andoh: Innovator in Anti-Cancer Research

Introduction

Nobuharu Andoh is a prominent inventor based in Kawachinagano, Japan. He has made significant contributions to the field of anti-cancer research, holding a total of 7 patents. His work focuses on developing innovative solutions that enhance safety and efficacy in cancer treatment.

Latest Patents

One of his latest patents is an anti-cancer agent comprising an aminoacetonitrile compound as the active ingredient. This invention relates to an anticancer agent that boasts high safety and superior anticancer activity. The compound is represented by a specific formula, where various groups and atoms are defined to ensure its effectiveness. The invention aims to provide a pharmacologically acceptable salt that can be utilized in cancer therapies.

Career Highlights

Throughout his career, Nobuharu Andoh has worked with notable companies such as Nihon Nohyaku Co., Ltd. and Pitney Pharmaceuticals Pty Limited. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to groundbreaking research.

Collaborations

Nobuharu has collaborated with esteemed colleagues, including Tomokazu Hino and Osamu Sanpei. These partnerships have fostered a collaborative environment that enhances the development of innovative cancer treatments.

Conclusion

Nobuharu Andoh's contributions to anti-cancer research exemplify his dedication to innovation in the pharmaceutical industry. His patents reflect a commitment to improving patient outcomes through advanced therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…